“SGRT provides the potential to reduce treatment-related errors which could affect patient outcomes, especially within the realm of hypo-fractionated treatments.”
– Juergen Meyer, University of Washington Medical Center and Department of Radiation Oncology, Seattle Cancer Care Alliance, Seattle, WA, USA, and senior author for the study.
C-RAD offers a full range of SGRT solutions, along with robust training, implementation and vendor integration to help ensure the best possible treatment outcome while maximizing efficiency for the treatment team.
You might also be interested in
From improving DIBH to enabling novel low-dose treatments, these case stories and webinars offer insights from frontline teams using C-RAD’s SGRT across real-world clinical settings. Supporting Precision, Without Adding Complexity…
I was recently honored to be interviewed by two major publications in Colombia—La Nota Económica and La Patria—to discuss how Surface Guided Radiation Therapy (SGRT) is transforming cancer treatment in…
Contact us
Contact your local office
We have service support groups the USA, China, Germany, France & Sweden
